Connect with us at BIO-Europe Spring 2021!
March 5th, 2021
KLUS Pharma will attend BIO Europe-Spring Digital Event held on March 22-25, 2021.
December 5th, 2020
KLUS Pharma will attend BIO Partnering at JPM Digital Event held on January 11-15, 2021.
June 1st, 2020
We are looking for partnerships to develop and distribute ACV200-17, a peptide drug to prevent COVID-19, in affected countries.
September 2nd, 2020
The IND for KL-A289, an anti-LAG-3 monoclonal antibody, was recently approved by the NMPA in China.
May 7th, 2020
KLUS Pharma will present an update for SKB264, a novel TROP2 ADC undergoing a Phase 1/2 clinical trial.
April 25th, 2020
KLUS Pharma will present clinical updates for our HER2 and TROP2 ADC programs at ASCO held on May 29-31, 2020.